Login

In the Engadget interview, HTC CEO Peter Chou talks about the company's innovation strategies, challenges, and future vision. 00:10:00

Share On Facebook Share On Twitter

Cher Wang serves as the CEO / President of HTC Corp.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ciena CEO Gary Smith discusses the acquisition of Cyan.
00:10:00
"EB5 Investors Project Update: Mark Davies and Peter Calabrese Discuss the CanAm Spiral Project and Investor Developments"
00:10:00
Piotr Figarski Discusses Image Power's 2022 Results and Future Trends | Piotr Figarski, Vice President , Image Power SA.
00:10:00
operators whove built companies cumulatively|Ashok Krishnamurthi,Managing Partner,GreatPoint Ventures
00:10:00
In Conversation with Angshu Mallick: Steering Adani Wilmar to Market Leadership | Angshu Mallick, CEO , Adani Wilmar Ltd.
00:10:00
Robert Thompson Discusses the Future of Newspapers and Media Transformation
00:10:00
Tribeca Investment Partners' Guy Keller on Nuclear Energy Opportunities Fund Performance and Uranium Market Insights
00:10:00
Interview with John Forwood, CIO of Lowell Resources
00:10:00
Rebecca Gold Project: Exciting Discovery Driving Near-Term Development in WA
00:10:00
Chief Technology Officer Michael Tolentino, MD, is with Aviceda Therapeutics. | Mohamed Genead, MD, CHIEF EXECUTIVE OFFICER, AVICEDA THERAPEUTICS INC
00:10:00
Highcroft Mining: Advancing a World-Class Gold and Silver Project with Strategic Investments and Experienced Leadership
00:10:00
CEO of Airgain Jacob Suen Participates in the Big Biz Show to Talk About the Craft of Wireless Simplification | Jacob Suen, President and Chief Executive Officer, Airgain Inc AIRG:NAQ

© 2026 Nehu